SG/CALL/VERTEX PHARMACEUTICALS/550/0.1/19.09.25 | Market Closed - Bid/Ask 03:53:15 2024-05-15 EDT | After market 15:07:07 | |||
| 2.99 EUR | -0.33% |
|
3.405 | +13.88% |
| Current month | +44.93% | ||
| 1 month | +16.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 2.99 | -0.33% |
| 24-05-14 | 3 | +7.91% |
| 24-05-13 | 2.78 | +3.35% |
| 24-05-10 | 2.69 | +3.86% |
| 24-05-09 | 2.59 | +10.21% |
Delayed Quote Börse Stuttgart
Last update May 15, 2024 at 03:53 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Société Générale
|
| WKN | SU95V8 |
| ISIN | DE000SU95V88 |
| Date issued | 2024-03-01 |
| Strike | 550 $ |
| Maturity | 2025-09-19 (492 Days) |
| Parity | 10 : 1 |
| Emission price | 3.9 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.86 € |
|---|---|
| Lowest since issue | 2.07 € |
| Delta | 0.4x |
| Omega | 4.683 |
| Premium | 34.33x |
| Gearing | 11.76x |
| Moneyness | 0.7947 |
| Difference Strike | 112.7 $ |
| Difference Strike % | +20.49% |
| Spread | 0.05 € |
| Spread % | 1.45% |
| Theoretical value | 3.415 |
| Implied Volatility | 31.44 % |
| Total Loss Probability | 73.35 % |
| Intrinsic value | 0.000000 |
| Present value | 3.415 |
| Break even | 587.15 € |
| Theta | -0.05x |
| Vega | 0.18x |
| Rho | 0.17x |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
428.6
USD
Average target price
462.6
USD
Spread / Average Target
+7.92%
- Stock Market
- Warrants
- Warrant
